Suppr超能文献

经股静脉通路有助于上肢透析干预:操作成功率和临床结果。

Transfemoral Venous Access Facilitates Upper Extremity Dialysis Interventions: Procedural Success and Clinical Outcomes.

作者信息

Wang J W, Padia S A, Lee E W, Moriarty J M, McWilliams J P, Kee S T, Plotnik A N, Sayre J W, Srinivasa R N

机构信息

Department of Radiology, Division of Vascular and Interventional Radiology, University of California at Los Angeles, 757 Westwood Plaza, Los Angeles, CA, 90095, USA.

Department of Biostatistics, UCLA School of Public Health, Los Angeles, CA, 90095, USA.

出版信息

Cardiovasc Intervent Radiol. 2019 Mar;42(3):460-465. doi: 10.1007/s00270-018-02154-w. Epub 2019 Jan 2.

Abstract

PURPOSE

To report technical success and clinical outcomes of transfemoral venous access for upper extremity dialysis interventions.

MATERIALS AND METHODS

A total of 15 patients underwent a transfemoral venous approach for fistulography (n = 4; 27%) or thrombectomy (n = 11; 73%) over a 14-month period. Access characteristics, sheath size, thrombectomy method, angioplasty site, fluoroscopy time, radiation dose, technical and clinical success, complications, and post-intervention primary and secondary patency rates were recorded.

RESULTS

Access type included arteriovenous fistulas (n = 10; 67%) and grafts (n = 5; 33%). The most common configuration was brachio-brachial (n = 6; 38%). Mean age of access was 37 months. Mean prior interventions were 4. Right CFV access was used in all patients using 6-8-French (most common: 7-French [n = 10; 67%]) sheaths. Most thrombectomies (n = 11; 73%) required both pharmacologic and mechanical maceration (n = 9; 82%). All accesses required angioplasty to treat underlying stenosis at the outflow vein (n = 12; 80%) or arteriovenous anastomosis (n = 9; 90%). Mean fluoroscopy time was 26.43 min. Air kerma and dose area product were 178.06 ± 225.77 mGy and 57,768.83 ± 87,553.29 μGym, respectively. Procedural and clinical success rates were 93% and 80%, respectively. Technical failure was due to persistent stenosis in one patient. Clinical failure was due to unsuccessful dialysis immediately following intervention in three patients. Mean post-intervention primary patency and secondary patency durations were 2.8 and 4.8 months, respectively. Primary patency rates at 1 and 3 months were 50% and 35%, respectively. Secondary patency rates at 1 and 3 months were 58% and 30%, respectively.

CONCLUSION

A transfemoral venous approach for intervention of upper extremity dialysis accesses may be a valuable adjunct to traditional approaches.

摘要

目的

报告经股静脉途径用于上肢透析干预的技术成功率和临床结果。

材料与方法

在14个月期间,共有15例患者接受了经股静脉途径进行的瘘管造影(n = 4;27 %)或血栓切除术(n = 11;73 %?)。记录通路特征、鞘管尺寸、血栓切除方法、血管成形术部位、透视时间、辐射剂量、技术和临床成功率、并发症以及干预后的初次和二次通畅率。

结果

通路类型包括动静脉内瘘(n = 10;67 %)和移植物(n = 5;33 %)。最常见的构型是肱 - 肱型(n = 6;38 %)。通路的平均使用时间为37个月。既往平均干预次数为4次。所有患者均采用右股总静脉通路,使用6 - 8法国规格(最常见:7法国规格 [n = 10;67 %])的鞘管。大多数血栓切除术(n = 11;73 %)需要药物和机械溶栓联合使用(n = 9;82 %)。所有通路均需要进行血管成形术,以治疗流出静脉(n = 12;80 %)或动静脉吻合口(n = 9;90 %)的潜在狭窄。平均透视时间为26.43分钟。空气比释动能和剂量面积乘积分别为178.06 ± 225.77 mGy和57,768.83 ± 87,553.29 μGym。手术成功率和临床成功率分别为93 %和80 %。技术失败是由于1例患者存在持续性狭窄。临床失败是由于3例患者在干预后立即进行透析未成功。干预后的初次通畅和二次通畅平均持续时间分别为2.8个月和4.8个月。1个月和3个月时的初次通畅率分别为50 %和35 %。1个月和3个月时的二次通畅率分别为58 %和30 %。

结论

经股静脉途径用于上肢透析通路的干预可能是传统方法的一种有价值的辅助手段。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验